Acute myeloid leukemia pediatric · 4 regimens
Cost vs Efficacy
| Regimen | Biomarker | Cost/cycle ↓ | Cycle | PFS ↕ | OS ↕ | Est. cycles | Course cost ↕ | Evidence |
|---|---|---|---|---|---|---|---|---|
Busulfan and Cyclophosphamide Variant #01 | — | R 6 777 | — | — | — | ~1 | ~R 6 777 indirect | — |
MACE Variant #01 Partial | — | R 2 943 | 5d | — | — | ~1 | ~R 2 943 indirect | — |
Cyclophosphamide and TBI, then allo HSCT Variant #01 Partial | — | R 1 176 | — | — | — | ~1 | ~R 1 176 indirect | — |
BuCy Partial | — | — | — | — | — | — | — | — |
4 of 4 regimens shown